The effects of Cstb duplication on APP/amyloid-β pathology and cathepsin B activity in a mouse model.
People with Down syndrome (DS), caused by trisomy of chromosome 21 have a greatly increased risk of developing Alzheimer's disease (AD). This is in part because of triplication of a chromosome 21 gene, APP. This gene encodes amyloid precursor protein, which is cleaved to form amyloid-β that acc...
Guardado en:
Autores principales: | Yixing Wu, Heather T Whittaker, Suzanna Noy, Karen Cleverley, Veronique Brault, Yann Herault, Elizabeth M C Fisher, Frances K Wiseman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ef70aabd7c9645f4a1ceae65bf660fef |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genetic dissection of down syndrome-associated alterations in APP/amyloid-β biology using mouse models
por: Justin L. Tosh, et al.
Publicado: (2021) -
Publisher Correction: Genetic dissection of down syndrome‑associated alterations in APP/amyloid‑β biology using mouse models
por: Justin L. Tosh, et al.
Publicado: (2021) -
Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice.
por: Eric A Tanifum, et al.
Publicado: (2012) -
<i>Dyrk1a</i> from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome
por: Helin Atas-Ozcan, et al.
Publicado: (2021) -
Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice.
por: Nikisha Carty, et al.
Publicado: (2013)